Christopher Toombs, Ph.D.

Dr. Chris Toombs is a 20-year industry veteran and an experienced cardiovascular pharmacologist working in the preclinical stage of therapeutic product development. Currently, Dr. Toombs is a co-founder and Chief Scientific Officer of Proniras Corporation (an Accelerator Life Science Partners’ portfolio company).  Prior to this Dr. Toombs was a co-founder and Chief Scientific Officer of Faraday Pharmaceuticals and served as Senior Director Preclinical Development at Ikaria. Before Ikaria, Dr. Toombs served in increasing roles and responsibilities in research and product development at Amgen for over ten years.

Dr. Toombs received a BS in Biology from Wheaton College and continued to earn a PhD in Physiology-Pharmacology from the Bowman Gray School of Medicine at Wake Forest University. He completed a postdoctoral tenure at Upjohn Laboratories and is a current Diplomate of the American Board of Toxicology.